Fresenius Medical Care announced today that it will invest $25 million in Humacyte in connection with the merger of Humacyte and a SPAC. Humacyte, which develops implantable human acellular vessels for multiple vascular repair, reconstruction and replacement, entered into a merger with a special purpose acquisition company (SPAC), leading Fresenius to increase its position in […]
Fresenius Medical Care
Fresenius to provide more home dialysis machines to DaVita
Fresenius Medical Care North America (FMCNA) has expanded its agreement with DaVita Kidney Care to provide NxStage home hemodialysis machines and related technology to DaVita’s U.S. patients. “We are excited to expand our longstanding collaboration with DaVita to help more patients benefit from the portability, dependability, and flexibility of our NxStage home machines, which are […]
CMS delays shift to new payment model for chronic kidney disease treatments
CMS will now wait until Jan. 1, 2022 to start its Kidney Care Choices model, meant to shift the way the U.S. treats chronic kidney disease. The new payment model was supposed to start on Jan. 1 of this year, but health providers are still grappling with the COVID-19 pandemic. The new model could have […]
The 11 largest medtech employers of 2020 – and what their employees really think
Employees of the 11 largest medtech employers are proud of working on life-saving products with added benefits due to the COVID-19 pandemic, but also reported frustration with big corporate bureaucracy. That was one major takeaway as Medical Design & Outsourcing compiled some current and former employee reviews posted on Glassdoor. The companies are the largest […]
Fresenius wins FDA approval for next-gen dialysis solution bags
Fresenius Medical Care North America (NYSE:FMS) recently announced that FDA has approved its Deleflex peritoneal dialysis solutions bagged in its less wasteful Biofine material. Company officials expect the new Biofine peritoneal solutions bag to be first available to a limited number of patients in the U.S. this fall. “The new Biofine peritoneal dialysis solutions line is […]
Fresenius to enter heart, lung, organ failure markets
Fresenius Medical Care (NYSE:FMS) announced today that its new growth strategy includes treating heart, lung and multi-organ failure. Hamburg, Germany-based Fresenius’ strategy centers around three major areas: renal care, critical care solutions and complementary assets, according to a news release. The company’s renal care continuum is to be bolstered by artificial intelligence and data analysis technologies […]
Fresenius Medical Care expands transitional care in the U.S.
Fresenius Medical Care said it is expanding its transitional care units in the U.S. this year. The company plans to open more than 100 new TCUs in 2020 to help people recently diagnosed with kidney failure to learn about the treatment options available, including home dialysis. TCUs are designed as a separate space within a […]
Fresenius Medical Care North America launches connected health platform
Fresenius (NYSE:FMS) recently announced that its Fresenius Medical Care North America (FMCNA) business has launched a connected health platform called TheHub. TheHub includes three integrated applications meant to enable people on dialysis, their care teams, and health providers to better collaborate. Fresenius officials see the system enhancing remote monitoring for people on home dialysis. The Trump administration […]
Fresenius Medical Care wins FDA breakthrough nod for clot-preventing dialysis device
Fresenius Medical Care North America (NYSE:FMS) said today that it won breakthrough device designation from the FDA for the new hemodialysis system it’s developing. Waltham, Mass.-based Fresenius said its Endexo antithrombogenic additive is being incorporated into the manufacturing of dialyzers and bloodlines. The device is a polymer made of modifying molecules designed to inhibit the adsorption […]
Report: Fresenius to shutter Ohio billing operation, lay off 57
Fresenius Management Services (NYSE:FMS; ETR:FRE) is reportedly closing its medical billing facility and laying off nearly 60 employees in North Olmsted, Ohio. The company filed a Worker Adjustment and Retraining Notification on Oct. 4 saying that it would lay off 56 employees on December 6 and add one more employee to the layoffs on Jan. […]
Fresenius settles Medicare over-billing case for $5m
Fresenius Medical Care (NYSE:FMS; ETR:FRE) agreed to pay more than $5 million to resolve allegations that its dialysis clinic business over-billed Medicare for hepatitis B tests. The country’s largest dialysis clinic operator, Fresenius Medical Care North America agreed to pay $5.2 million to settle federal prosecutors’ allegations that it billed Medicare for tests of dialysis patients […]
